FMT
MRSN

First Mercantile Trust’s Mersana Therapeutics MRSN Stock Holding History

First Mercantile Trust’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$52K Sell
222
-9
-4% -$2.63K 0.01% 774
2021
Q2 		$78K Sell
231
-14
-6% -$5.3K 0.01% 745
2021
Q1 		$99K Buy
245
+84
+52% +$40.7K 0.01% 684
2020
Q4 		$107K Sell
161
-66
-29% -$36.7K 0.01% 670
2020
Q3 		$130K Buy
227
+68
+43% +$34.4K 0.02% 587
2020
Q2 		$93K Buy
+159
New +$54.3K 0.01% 693

Other funds holding MRSN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

First Mercantile Trust's MRSN Position: Q3 2021 in Review

First Mercantile Trust reduced its Mersana Therapeutics (MRSN) stake by 3.9% in Q3 2021, selling an estimated $2.63K and leaving 222 shares worth $52K. The position accounts for 0.01% of the portfolio, ranked #774.

First Mercantile Trust first reported a position in MRSN in Q2 2020 and has held it in 6 quarters since. The position peaked at $130K in Q3 2020. 109 funds tracked by Wall St. Rank hold MRSN as of Q3 2021.

  • First Mercantile Trust held 222 shares of Mersana Therapeutics worth $52K as of Q3 2021.
  • First Mercantile Trust sold 9 Mersana Therapeutics shares in Q3 2021, an estimated $2.63K.
  • Mersana Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #774 holding.
  • First Mercantile Trust first reported a position in Mersana Therapeutics in Q2 2020 and has held it in 6 quarters since.
  • First Mercantile Trust's Mersana Therapeutics position peaked at $130K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.